Myelodysplastic syndromes (MDS)
Myelodysplastic syndromes (MDS) is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
"Myelodysplastic Syndromes (MDS)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454121/all/Myelodysplastic_syndromes__MDS_.
Myelodysplastic syndromes (MDS). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454121/all/Myelodysplastic_syndromes__MDS_. Accessed March 30, 2023.
Myelodysplastic syndromes (MDS). (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454121/all/Myelodysplastic_syndromes__MDS_
Myelodysplastic Syndromes (MDS) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454121/all/Myelodysplastic_syndromes__MDS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Myelodysplastic syndromes (MDS) ID - 454121 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454121/all/Myelodysplastic_syndromes__MDS_ PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -